Future CNS Clinical Development Driven by Market Access Evaluation: The Payer Centric Approach

May 27, 2013 - LONDON, U.K. -- Future CNS Clinical Development Programs have to be directly linked to the evolving CNS drug market where the patient effectively makes the decision about their health.

http://www.prlog.org/12144176-future-cns-clinical-development-driven-by-market-access-evaluation-the-payer-centric-approach.html